Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies is a UK-based pharmaceutical company specialised in cannabinoid drug development. The Company's vision is to become a global leader in developing licensed prescription medicines that target the endocannabinoid system and address significant unmet medical needs with a primary focus on the pain market. The Company's strategy is to develop cannabinoid pharmaceuticals for the safe, effective, and non-addictive treatment of pain conditions, through GMP manufactured and dose-consistent prescription medicines that have undergone rigorous randomised, controlled clinical trials with regulatory marketing approval.